![Biocon Biologics receives EMA approval for cancer drug](https://images.assettype.com/fortuneindia%2F2017-07%2F65ac5d52-00f1-487d-9f56-514ee719148f%2Fimage.jpg?w=300&q=95)
Biocon Biologics receives EMA approval for cancer drug
The company received approval from the European Medicines Agency to manufacture biosimilar Bevacizumab at its new, multi-product monoclonal antibodies drug substance facility in Bengaluru.
The company received approval from the European Medicines Agency to manufacture biosimilar Bevacizumab at its new, multi-product monoclonal antibodies drug substance facility in Bengaluru.